Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
4 "Young Eun Kim"
Filter
Filter
Article category
Keywords
Publication year
Authors
Case Reports
Gastric Adenocarcinoma of Fundic Gland Type: Report of Three Cases
Eun Su Park, Young Eun Kim, Cheol Keun Park, Takashi Yao, Ryoji Kushima, Kyoung-Mee Kim
Korean J Pathol. 2012;46(3):287-291.   Published online June 22, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.3.287
  • 9,592 View
  • 103 Download
  • 24 Crossref
AbstractAbstract PDF

Recently, fundic gland type gastric adenocarcinoma (GA-FG) has been reported as a new entity. This report describes GA-FG among Koreans for the first time. From March 2008 to July 2010 we identified only three cases of GA-FG out of over 6,000 GAs resected by endoscopy or surgery. Cell differentiation by mucin proteins, pepsinogen-I, and H+/K+-ATPase was evaluated. All three cases were male patients and diagnosed as early stage GA. Histologically, GA-FGs were well-differentiated adenocarcinoma with pale gray-blue, basophilic columnar or cuboidal cells and mildly enlarged nuclei, resembling chief cells. All three cases were positive for pepsinogen-I and were classified as gastric mucin phenotype. Among three histologic subtypes of GA-FG, since tumors were mainly composed of chief cells, our three cases were classified as chief cell predominant type. In conclusion, GA-FG is very rare among Koreans and pepsinogen-I and MUC6 expression are typical immunohistochemical findings in GA-FG suggesting differentiation toward fundic glands.

Citations

Citations to this article as recorded by  
  • Oxyntic Gland Neoplasms - From Adenoma to Advanced Gastric Cancer: A Review of 29 Cases
    Gi Hwan Kim, Jun Su Lee, Jeong Hoon Lee, Young Soo Park
    Journal of Gastric Cancer.2024; 24(4): 378.     CrossRef
  • Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2-1/TTF-1) in gastric adenocarcinoma of fundic-gland type
    Kazushi Fukagawa, Yu Takahashi, Nobutake Yamamichi, Natsuko Kageyama-Yahara, Yoshiki Sakaguchi, Miho Obata, Rina Cho, Nobuyuki Sakuma, Sayaka Nagao, Yuko Miura, Naoki Tamura, Daisuke Ohki, Hiroya Mizutani, Seiichi Yakabi, Chihiro Minatsuki, Keiko Niimi, Y
    Gastric Cancer.2023; 26(1): 44.     CrossRef
  • Clinicopathological Features and the Prevalence of Oxyntic Gland Neoplasm: A Single-center Retrospective Study
    Hikari Asahara, Toshitatsu Takao, Yumiko Asahara, Masakyo Asahara, Douglas Motomura, Hiroya Sakaguchi, Tetsuya Yoshizaki, Nobuaki Ikezawa, Madoka Takao, Yoshinori Morita, Takashi Toyonaga, Masato Komatsu, Ryoji Kushima, Yuzo Kodama
    Internal Medicine.2023; 62(19): 2763.     CrossRef
  • Clinicopathological features of gastric adenocarcinoma of fundic gland type
    Bao-Zhen Guo, Zhen-Zhen Liu, Gao-Fei Shen, Fei Zhu, Hui-Fen Lian, Xin Li, Jun-Yi Zheng, Jin-Peng Li, Shui-Miao Deng, Rui Huang
    World Chinese Journal of Digestology.2023; 31(6): 244.     CrossRef
  • Endoscopic Resection for Gastric Adenocarcinoma of the Fundic Gland Type: A Case Series
    Hwa Jin Lee, Gwang Ha Kim, Dong Chan Joo, Moon Won Lee, Bong Eun Lee, Kyungbin Kim
    The Korean Journal of Gastroenterology.2023; 81(6): 259.     CrossRef
  • Gastric adenocarcinoma of the fundic gland type: A review of the literature
    Zhiyong Zhai, Wei Hu, Zhaoyu Huang, Zemin Chen, Sicun Lu, Wei Gong
    JGH Open.2023; 7(12): 812.     CrossRef
  • Clinicopathological features of early stage gastric adenocarcinoma of fundic gland type
    Huan Zhang, Shuyan Wang, Yongping Zhang, Fusang Ye, Chunnian Wang
    Medicine.2022; 101(2): e28469.     CrossRef
  • Gastric Adenocarcinoma of Fundic Gland Type Treated by Endoscopic Submucosal Dissection
    Yong Bo Park, Gwang Ha Kim, Kyungbin Kim, Tae Kyoung Ha, Guk Bin Park, Young Min Kwak
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(1): 82.     CrossRef
  • Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type
    Hiroya Ueyama, Takashi Yao, Yoichi Akazawa, Takuo Hayashi, Koichi Kurahara, Yumi Oshiro, Masayoshi Yamada, Ichiro Oda, Shin Fujioka, Chiaki Kusumoto, Masayoshi Fukuda, Kunihisa Uchita, Tomohiro Kadota, Yasuhiro Oono, Kazuhisa Okamoto, Kazunari Murakami, Y
    Journal of Gastroenterology.2021; 56(9): 814.     CrossRef
  • Endoscopic resection is a suitable initial treatment strategy for oxyntic gland adenoma or gastric adenocarcinoma of the fundic gland type
    Masaya Iwamuro, Chiaki Kusumoto, Masahiro Nakagawa, Sayo Kobayashi, Masao Yoshioka, Tomoki Inaba, Tatsuya Toyokawa, Shinichiro Hori, Shouichi Tanaka, Kazuhiro Matsueda, Takehiro Tanaka, Hiroyuki Okada
    Scientific Reports.2021;[Epub]     CrossRef
  • A series of five patients with oxyntic gland adenoma: Deciphering the clinical and histological features of these rare gastric polyps
    Jerry C. Nagaputra, Tracy Jie Zhen Loh, Sangeeta Mantoo, Rafay Azhar, Vikneswaran Namasivayam, Wei Qiang Leow
    Human Pathology Reports.2021; 26: 300566.     CrossRef
  • Gastric adenocarcinoma of the fundic gland: A review of clinicopathological characteristics, treatment and prognosis
    Xiang-yu Meng, Guang Yang, Cheng-ji Dong, Ru-yi Zheng
    Rare Tumors.2021;[Epub]     CrossRef
  • Gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection
    Chengfang Li, Xinglong Wu, Shuang Yang, Xiaorong Yang, Jin Yao, Hong Zheng
    Diagnostic Pathology.2020;[Epub]     CrossRef
  • Multiple gastric adenocarcinoma of fundic gland type: A case report
    Ou Chen, Ze-Yong Shao, Xiong Qiu, Guang-Ping Zhang
    World Journal of Clinical Cases.2019; 7(18): 2871.     CrossRef
  • Gastric Adenocarcinoma of the Fundic Gland Type
    Mark A Benedict, Gregory Y Lauwers, Dhanpat Jain
    American Journal of Clinical Pathology.2018; 149(6): 461.     CrossRef
  • Oxyntic Gland Adenoma Treated by Endoscopic Mucosal Resection
    In Ji Song, Jin Woo Joo, Jun Chul Park, Sung Kwan Shin, Yong Chan Lee, Sang Kil Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2017; 17(2): 94.     CrossRef
  • Chief cell‐predominant gastric polyps: a series of 12 cases with literature review
    Karen Chan, Ian S Brown, Trevor Kyle, Gregory Y Lauwers, Marian Priyanthi Kumarasinghe
    Histopathology.2016; 68(6): 825.     CrossRef
  • Twelve-year natural history of a gastric adenocarcinoma of fundic gland type
    Yoshinori Sato, Takashi Fujino, Akira Kasagawa, Ryo Morita, Shun-ichiro Ozawa, Yasumasa Matsuo, Tadateru Maehata, Hiroshi Yasuda, Masayuki Takagi, Fumio Itoh
    Clinical Journal of Gastroenterology.2016; 9(6): 345.     CrossRef
  • Clinicopathological features of gastric adenocarcinoma of the fundic gland (chief cell predominant type) by retrospective and prospective analyses of endoscopic findings
    Takashi Chiba, Katsuaki Kato, Takayuki Masuda, Shuichi Ohara, Noriyuki Iwama, Takenobu Shimada, Daisuke Shibuya
    Digestive Endoscopy.2016; 28(7): 722.     CrossRef
  • Gastric Adenocarcinoma of the Fundic Gland Type Treated by Endoscopic Mucosal Resection: A Case Report and Review of the Literature
    Eleanor Lewin, Philip Daroca, Sanjay Sikka, Tong Wu, Yukihiro Nakanishi
    Case Reports in Pathology.2016; 2016: 1.     CrossRef
  • Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): A review of endoscopic and clinicopathological features
    Masaki Miyazawa, Mitsuru Matsuda, Masaaki Yano, Yasumasa Hara, Fumitaka Arihara, Yosuke Horita, Koichiro Matsuda, Akito Sakai, Yatsugi Noda
    World Journal of Gastroenterology.2016; 22(48): 10523.     CrossRef
  • Oxyntic gland adenoma endoscopically mimicking a gastric neuroendocrine tumor: A case report
    Tae-In Lee
    World Journal of Gastroenterology.2015; 21(16): 5099.     CrossRef
  • Oxyntic gland polyp/adenoma
    Rajkumar Vajpeyi, Jyoti Dekate
    Diagnostic Histopathology.2014; 20(11): 446.     CrossRef
  • Gastric adenocarcinoma of fundic gland type with unusual behavior
    Tetsuya Ueo, Hirotoshi Yonemasu, Tetsuya Ishida
    Digestive Endoscopy.2014; 26(2): 293.     CrossRef
Metaplastic Thymoma: Report of 4 Cases
Guhyun Kang, Nara Yoon, Joungho Han, Young Eun Kim, Tae Sung Kim, Kwhanmien Kim
Korean J Pathol. 2012;46(1):92-95.   Published online February 23, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.1.92
  • 8,327 View
  • 63 Download
  • 14 Crossref
AbstractAbstract PDF

Metaplastic thymoma (MT), accepted in the World Health Organization 2004 scheme, is a circumscribed tumor of the thymus exhibiting biphasic morphology. We herein describe the clinicopathologic features of four MTs and the differential diagnoses of this unusual tumor. There were three women and one man with mean age of 49.5 years. The patients were found to have mediastinal masses, and underwent surgical excision. One exhibited symptoms of myasthenia gravis, and the serum titer for anti-acetylcholine receptor antibody was positive. Grossly, the tumors were encapsulated, and showed vaguely multinodular, solid, tan-white to yellow cut surfaces. Histologically, they comprised epithelial islands intertwining with bundles of delicate spindle cells. The patients remained well after surgical excision at 5-55 months. Because of the distinctive histological appearance and benign clinical course, MT should be distinguished from other more aggressive mediastinal neoplasms displaying biphasic feature.

Citations

Citations to this article as recorded by  
  • A Rare Case of Metaplastic Thymoma Presenting With Myasthenia Gravis
    Ilianne Vega Prado, John Shymansky, Anisha Apte, Keith Mortman, Henry J. Kaminski, Stephanie Barak
    International Journal of Surgical Pathology.2024; 32(1): 155.     CrossRef
  • Thymic epithelial tumours: histopathological classification and differential diagnosis
    Jan von der Thüsen
    Histopathology.2024; 84(1): 196.     CrossRef
  • Epigenetics of Thymic Epithelial Tumors
    Vanessa Nicolì, Fabio Coppedè
    Cancers.2023; 15(2): 360.     CrossRef
  • Expanding the Clinicopathologic Spectrum of YAP1::MAML2–Rearranged Thymic Neoplasm
    Eric Eunshik Kim, Ye Yoon Suh, Sang Won Lee, Jeong Mo Bae, Kyoungbun Lee, Sungyoung Lee, Hongseok Yun, Kyeong Cheon Jung, Jiwon Koh
    Modern Pathology.2023; 36(2): 100048.     CrossRef
  • Significance of YAP1–MAML2 rearrangement and GTF2I mutation in the diagnosis and differential diagnosis of metaplastic thymoma
    Minghao Wang, Hongtao Xu, Qiang Han, Liang Wang
    Annals of Medicine.2023;[Epub]     CrossRef
  • Loss of YAP1 C‐terminus expression as an ancillary marker for metaplastic thymoma: a potential pitfall in detecting YAP1::MAML2 gene rearrangement
    Xuan Wang, Lei‐lei Liu, Qing Li, Qiu‐yuan Xia, Rui Li, Sheng‐bing Ye, Ru‐song Zhang, Ru Fang, Hui Chen, Nan Wu, Qiu Rao
    Histopathology.2023; 83(5): 798.     CrossRef
  • A Case of Metaplastic Thymoma
    Ryoichi TAKENAKA, Kenji NEZU, Daijiro TAKEMOTO, Tatsuya HAYASHI, Hisato YAMAMOTO, Shoichi MATSUKAGE
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2023; 84(4): 538.     CrossRef
  • Malignant Transformation of Metaplastic Thymoma into High-Grade Sarcomatoid Carcinoma: A Case Report
    Zheng Hua Piao, Jin Ping Chen, Hai Ren Chen, Xin Cheng Zhou
    International Journal of Surgical Pathology.2022; 30(5): 564.     CrossRef
  • YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma
    Jikai Zhao, Ruiying Zhao, Chan Xiang, Jinchen Shao, Lianying Guo, Yuchen Han
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions
    Marina Vivero, Phani Davineni, Valentina Nardi, John K.C. Chan, Lynette M. Sholl
    Modern Pathology.2020; 33(4): 560.     CrossRef
  • Metaplastic thymoma: Report of two cases
    Yoshikazu Shinohara, Mariko Tanaka, Kentaro Kitano, Kazuhiro Nagayama, Masaaki Sato, Jun Nakajima
    The Journal of the Japanese Association for Chest Surgery.2020; 34(7): 733.     CrossRef
  • Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma
    Yukari Miki, Kana Hamada, Tadashi Yoshino, Katsuya Miyatani, Kiyoshi Takahashi
    Virchows Archiv.2014; 464(6): 725.     CrossRef
  • Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck
    Jae Myoung Noh, Sang Yun Ha, Yong Chan Ahn, Dongryul Oh, Seung Won Seol, Young Lyun Oh, Joungho Han
    Cancer Research and Treatment.2014; 47(3): 436.     CrossRef
  • A Case of Metaplastic Thymoma
    Eiji MIYAHARA, Tomoko ITAGAKI, Masaki KUWAHARA, Akira KAMEDA, Yoshihiro MIYATA, Kazuhiro SENTANI, Wataru YASUI
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2014; 75(2): 360.     CrossRef
Original Articles
SSTR2A Protein Expression in Neuroendocrine Neoplasms of the Colorectum.
Young Eun Kim, Jeeyun Lee, Young Suk Park, Kyoung Mee Kim
Korean J Pathol. 2011;45(3):276-280.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.3.276
  • 3,425 View
  • 21 Download
AbstractAbstract PDF
BACKGROUND
Expression studies of somatostatin receptor type 2A (SSTR2A) in neuroendocrine neoplasms (NENs) led to the development of clinically relevant diagnostic and therapeutic strategies. However, most of these strategies used in-house-developed antibodies and were focused on lung tumors. We evaluated commercially available SSTR2A antibodies in NENs of the colorectum to observe their subcellular localization and distribution within the resected tumor.
METHODS
The immunohistochemistry of 77 NENs located in the colorectum were studied using a commercially available antibody against SSTR2A.
RESULTS
Most neuroendocrine tumors (NET) grade (G)1 and G2 expressed the SSTR2A in the cytoplasm with apical or luminal localization. However, all neuroendocrine carcinomas (NEC) G3 were negative for SSTR2A.
CONCLUSIONS
Our data indicate that SSTR2A immunohistochemistry shows cytoplasmic staining with distinct subcellular localization in most NET G1 in the colorectum using a commercially available antibody. Low or no expression of SSTR2A in NET G2 and NEC G3 raises the possibility that SSTR2A may correlate with histologic differentiation and proliferative activity. Further validation studies in large case series are needed.
Mucoepidermoid Carcinoma of Tracheobronchial Tree: Clinicopathological Study of 31 Cases.
Sang Yun Ha, Joungho Han, Jae Jun Lee, Young Eun Kim, Yoon La Choi, Hong Kwan Kim
Korean J Pathol. 2011;45(2):175-181.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.2.175
  • 4,185 View
  • 31 Download
  • 8 Crossref
AbstractAbstract PDF
BACKGROUND
All aspects of mucoepidermoid carcinoma (MEC) of the lung including histologic grading, clinical behavior and its differentiation from adenosquamous cell carcinoma are still not fully understood.
METHODS
We reviewed the hematoxylin-eosin stained slides and medical records of 31 cases of MEC of the lungs. The cases were classified as low and high grade according to the quantitative grading system formulated for MEC. High grade tumors were tested for an epidermal growth factor receptor (EGFR) mutation.
RESULTS
Twenty eight cases were classified as low grade and 3 cases as high grade. Histologically, lower glandular component, cellular atypia, necrosis, mitoses >4/10 high power fields, and endolymphatic tumor emboli were typical characteristics of a high grade tumor. Although some tumors showed histologic features mimicking high grade tumors, they were classified as low grade tumors according to this quantitative grading system. Low grade tumors showed no recurrence or metastasis. However, among three patients with a high grade tumor, two had distant metastases and one died of disease. Additionally, an EGFR mutation was not detected.
CONCLUSIONS
A high grade MEC was consistently different from a low grade tumor with regard to malignant histologic features and poor prognosis. Therefore, correct histologic grading is important in predicting the prognosis to avoid unnecessary treatment.

Citations

Citations to this article as recorded by  
  • A rare case of endobronchial mucoepidermoid carcinoma of the lung presenting as non-resolving pneumonia
    Toolsie Omesh, Ranjan Gupta, Anjali Saqi, Joshua Burack, Misbahuddin Khaja
    Respiratory Medicine Case Reports.2018; 25: 154.     CrossRef
  • Cutaneous Involvement by Nasal Mucoepidermoid Carcinoma: The Tip of the Iceberg Phenomenon
    Ge Zhao, Oliver Chang, John Streidl, Amit Bhrany, Kyle Garton, Timothy H. McCalmont, Paul E. Swanson, Zsolt Argenyi, Michi M. Shinohara
    Journal of Cutaneous Pathology.2017; 44(2): 113.     CrossRef
  • Surgical outcomes of pulmonary mucoepidermoid carcinoma: A review of 41 cases
    Chih-Cheng Hsieh, Yung-Han Sun, Shih-Wei Lin, Yi-Chen Yeh, Mei-Lin Chan, Pei-Yi Chu
    PLOS ONE.2017; 12(5): e0176918.     CrossRef
  • Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers
    Boram Lee, Taebum Lee, Se-Hoon Lee, Yoon-La Choi, Joungho Han
    Oncotarget.2016; 7(17): 23874.     CrossRef
  • Metastatic Pulmonary Mucoepidermoid Carcinoma with Fulminant Clinical Course
    Yong Won Park, Seon Bin Yoon, Mi Ju Cheon, Young Min Koh, Hyeon Sik Oh, Se Joong Kim, Seung Hyeun Lee
    The Ewha Medical Journal.2015; 38(2): 85.     CrossRef
  • Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR
    Sang Yun Ha, So-Jung Choi, Jong Ho Cho, Hye Joo Choi, Jinseon Lee, Kyungsoo Jung, Darry Irwin, Xiao Liu, Maruja E. Lira, Mao Mao, Hong Kwan Kim, Yong Soo Choi, Young Mog Shim, Woong Yang Park, Yoon-La Choi, Jhingook Kim
    Oncotarget.2015; 6(7): 5465.     CrossRef
  • Bronchoscopic Resection of an Exophytic Endoluminal Tracheal Mass
    Russell J. Miller, Septimiu D. Murgu
    Annals of the American Thoracic Society.2013; 10(6): 697.     CrossRef
  • EGFR mutations and mucoepidermoid carcinoma: Putative significance in differing populations
    Iain D. O’Neill
    Lung Cancer.2012; 78(1): 125.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP